Search Results

You are looking at 91 - 100 of 372 items for :

  • "therapeutics" x
  • Refine by Access: All x
Clear All
Full access

Open Notes Are Here: Are We Ready?

Margaret Tempero

Medicine and Director of the UCSF Pancreas Center and editor-in-chief of JNCCN . Her research career has focused on pancreatic ductal adenocarcinoma, especially in the area of investigational therapeutics. Dr. Tempero has served on the ASCO Board of

Full access

Informed Consent: Is It Really?

Margaret Tempero

Tempero, MD, is a Professor of Medicine and Director of the UCSF Pancreas Center and editor-in-chief of JNCCN . Her research career has focused on pancreatic ductal adenocarcinoma, especially in the area of investigational therapeutics. Dr. Tempero has

Full access

Failure Doesn’t Feel Good!

Margaret Tempero

investigational therapeutics. Dr. Tempero has served on the ASCO Board of Directors and as ASCO President. She currently serves on the ASCO Conquer Cancer Foundation Board. She codirected the AACR/ASCO Methods in Clinical Cancer Research and taught this course and

Full access

My Report Card

Margaret Tempero

research career has focused on pancreatic ductal adenocarcinoma, especially in the area of investigational therapeutics. Dr. Tempero has served on the ASCO Board of Directors and as ASCO President. She currently serves on the ASCO Conquer Cancer Foundation

Full access

How to Monitor Patients with Chronic Myelogenous Leukemia

Michael E O'Dwyer

The author participates in Speakers' Bureaus for Novartis Pharmaceuticals and Cell Therapeutics. References 1 Nowell PC Hungerford DA . A minute chromosome in human chronic granulocytic leukemia . Science 1960 ; 132 : 1497

Full access

Assuring Access to Academic Cancer Centers

Harold J. Burstein

through the NIH; to deny patients coverage for care at such facilities is to keep them away from programs that they built through financial support. It is also to deprive them of access to the emerging technologies and therapeutics that are reshaping

Full access

It’s About Time!

Margaret Tempero

Medicine and Director of the UCSF Pancreas Center and editor-in-chief of JNCCN . Her research career has focused on pancreatic ductal adenocarcinoma, especially in the area of investigational therapeutics. Dr. Tempero has served on the ASCO Board of

Full access

I Can’t Breathe!

Margaret Tempero

Professor of Medicine and Director of the UCSF Pancreas Center and editor-in-chief of JNCCN . Her research career has focused on pancreatic ductal adenocarcinoma, especially in the area of investigational therapeutics. Dr. Tempero has served on the ASCO

Full access

COVID-19 Affects JNCCN

Margaret Tempero

UCSF Pancreas Center and editor-in-chief of JNCCN . Her research career has focused on pancreatic ductal adenocarcinoma, especially in the area of investigational therapeutics. Dr. Tempero has served on the ASCO Board of Directors and as ASCO President

Full access

COVID-19 and Cancer: Unintended Consequences

Margaret Tempero

. Her research career has focused on pancreatic ductal adenocarcinoma, especially in the area of investigational therapeutics. Dr. Tempero has served on the ASCO Board of Directors and as ASCO President. She currently serves on the ASCO Conquer Cancer